References

1. Lloyd KM II, Dennis M. Cowden's disease. A possible new symptom complex with multiple system involvement. Ann Intern Med 1963; 58:136-142.

2. Hildenbrand C, Burgdorf WH, Lautenschlager S. Cowden syndrome—diagnostic skin signs. Dermatology 2001; 202(4):362-366.

3. Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet 2000; 37(11):828-830.

4. Nelen MR, Padberg GW, Peeters EA, et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 1996; 13(1):114-116.

5. Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg 1967; 54(3):191—195.

6. Torre D. Multiple sebaceous tumors. Arch Dermatol 1968; 98(5):549-551.

7. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995; 33(1):90-104.

8. Schreibman IR, Baker M, Amos C, et al. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 2005; 100(2):476-490.

9. Marignani PA. LKB1, the multitasking tumour suppressor kinase. J Clin Pathol 2005 ; 58(1): 15-19.

10. Pau H, Carney AS, Murty GE. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): otorhinolaryngological manifestations. Clin Otolaryngol Allied Sci 2001; 26(2): 93-98.

11. Bayrak-Toydemir P, Mao R, Lewin S, et al. Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians. Genet Med 2004; 6(4): 175-191.

12. Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129(1): 92-96.

13. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001; 137(3):357-364.

14. Leaute-Labreze C, Lamireau T, Chawki D, et al. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 2000; 83(4):347-352.

15. http://www.who.int/lep/ (accessed September 2005).

16. Ramos-e-Silva M, Rebello PF. Leprosy. Recognition and treatment. Am J Clin Dermatol 2001; 2 (4):203-211.

17. Ramos-E-Silva M, Oliveira ML, Munhoz-da-Fontoura GH. Leprosy: uncommon presentations. Clin Dermatol 2005; 23(5):509-514.

18. Kahan RS, Perez-Figaredo RA, Neimanis A. Necrolytic migratory erythema. Distinctive dermatosis of the glucagonoma syndrome. Arch Dermatol 1977; 113(6):792-797.

19. Wermers RA, Fatourechi V, Wynne AG, et al. The glucagonoma syndrome: clinical and pathologic features in 21 patients. Medicine (Baltimore) 1996; 75(2):53-63.

20. Chastain MA. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci 2001; 321(5):306-320.

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment